EPAM Cloud Pipeline, a cloud software application, is available on Microsoft Azure to support developers manage ‘constantly changing’ demands in analytics and modeling.
The purchase is aimed at expanding the company’s specialty diagnostics offerings in sample preparation technology, assay capabilities, bioinformatics and more.
As trial sites around the globe face the spread of the virus and ponder its bearing on their businesses, one industry executive wonders how ready they are.
Innovative Trials is set to work on increasing awareness within patient communities and improving engagement rates on behalf of Christie NHS Foundation Trust.
The two firms plan to use Saama’s Life Science Analytics Cloud platform to streamline clinical trial data management, using artificial intelligence technology.
Project ALS has selected Medidata’s biomarker discovery solution for its research projects, aiming to improve understanding of the ALS disease process and develop new therapeutic strategies.
After the Indian government moved to limit the export of APIs, an Indian export association says fear is spreading amongst European businesses over supply.
Domainex is set to support Lunac’s discovery project for anticoagulant therapies with reduced bleeding risk, following the developer’s novel target validation.
Raremark’s patient data and demographics will be integrated in TriNetX’s platform to help people with rare conditions access clinical trials and facilitate recruitment.
The health information technology company is looking at ways to alleviate the burdens clinical trial participants face, in order to improve recruitment and retention.
The clinical trial solutions provider has assembled a US-based network of advocates to help find ways to elevate patient access, experience and outcomes.
Clinical trials examining promising treatments against coronavirus face problems enrolling patients due to required criteria, experts at Duke Clinical Research Institute said.
With the supply of certain APIs limited by the spread of the virus, Indian government orders restrictions on the export of ingredients and formulations.
Arsenal has acquired BresMed to form a value demonstration company intended to support biopharmaceutical clients through strategy, evidence and communication tools.
Filed in 2017, Veeva Systems’ antitrust lawsuit alleges Iqvia has exacted ‘monopoly control’ restricting freedom in clinical trial software and data management.
The US FDA announces shortage of a drug due to a site affected by coronavirus, as it focuses on the protection of the supply chain from outbreak impacts.
The company’s Goes Direct effort seeks to partner with local doctors and other community healthcare providers to encourage broader representation in clinical trials.
As part of its efforts to reach a global settlement to resolve opioid claims, Mallinckrodt will file for Chapter 11 bankruptcy for its specialty generics subsidiary.
The latest Study Voices survey from BBK Worldwide indicates healthcare consumers and trial participants think alike towards technology, doctor access and quality of care.
Frontage has announced completion of its Pennsylvania site expansion to boost its offering of bioanalytical services for late-stage cell and gene therapies developers.
US FDA’s 2019 Drugs Trials Snapshots show female participation in clinical trials of the drugs approved during the past year increased, although ethnic diversity remains an issue.
Following an inspection at its Ireland site, Almac received compliance certification for its Almac Adapt Just in Time’ clinical packaging and labelling manufacturing services.
Lack of reproducibility in drug discovery has thrown the industry into crisis, scientists from Molecule and Arctoris claim, and suggest their discovery platform answers this challenge.
